These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 28508256)

  • 1. The Role of Micronutrients in Alopecia Areata: A Review.
    Thompson JM; Mirza MA; Park MK; Qureshi AA; Cho E
    Am J Clin Dermatol; 2017 Oct; 18(5):663-679. PubMed ID: 28508256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Vitamins and Minerals in Hair Loss: A Review.
    Almohanna HM; Ahmed AA; Tsatalis JP; Tosti A
    Dermatol Ther (Heidelb); 2019 Mar; 9(1):51-70. PubMed ID: 30547302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible role of β-hydroxybutyrate in inducing inflammation in alopecia areata.
    Shin JM; Son S; Jung KE; Kim CD; Lee Y
    Exp Dermatol; 2024 Jun; 33(6):e15117. PubMed ID: 38884504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micronutrient supplementation in adults with HIV infection.
    Visser ME; Durao S; Sinclair D; Irlam JH; Siegfried N
    Cochrane Database Syst Rev; 2017 May; 5(5):CD003650. PubMed ID: 28518221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of vitamin D and vitamin D receptor expression in patients with alopecia areata: a clinical paradigm.
    Daroach M; Narang T; Saikia UN; Sachdeva N; Sendhil Kumaran M
    Int J Dermatol; 2018 Feb; 57(2):217-222. PubMed ID: 29243839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCL13 is upregulated in alopecia areata lesions and is correlated with disease severity.
    Wang D; Xu X; Li X; Shi J; Tong X; Chen J; Lu J; Huang J; Yang S
    Exp Dermatol; 2021 May; 30(5):723-732. PubMed ID: 33523560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the Complex Immunopathogenesis of Alopecia Areata.
    Šutić Udović I; Hlača N; Massari LP; Brajac I; Kaštelan M; Vičić M
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mathematical model for alopecia areata.
    Dobreva A; Paus R; Cogan NG
    J Theor Biol; 2015 Sep; 380():332-45. PubMed ID: 26047853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata).
    Siebenhaar F; Sharov AA; Peters EM; Sharova TY; Syska W; Mardaryev AN; Freyschmidt-Paul P; Sundberg JP; Maurer M; Botchkarev VA
    J Invest Dermatol; 2007 Jun; 127(6):1489-97. PubMed ID: 17273166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hair follicle structures targeted by antibodies in patients with alopecia areata.
    Tobin DJ; Hann SK; Song MS; Bystryn JC
    Arch Dermatol; 1997 Jan; 133(1):57-61. PubMed ID: 9006373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
    Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
    Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alopecia areata: A multifactorial autoimmune condition.
    Simakou T; Butcher JP; Reid S; Henriquez FL
    J Autoimmun; 2019 Mar; 98():74-85. PubMed ID: 30558963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diphencyprone immunotherapy alters anti-hair follicle antibody status in patients with alopecia areata.
    Tobin DJ; Gardner SH; Lindsey NJ; Hoffmann R; Happle R; Freyschmidt-Paul P
    Eur J Dermatol; 2002; 12(4):327-34. PubMed ID: 12095876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alopecia Areata: a Comprehensive Review of Pathogenesis and Management.
    Trüeb RM; Dias MFRG
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):68-87. PubMed ID: 28717940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management.
    Paus R; Bulfone-Paus S; Bertolini M
    J Investig Dermatol Symp Proc; 2018 Jan; 19(1):S12-S17. PubMed ID: 29273098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of immunohistochemical expression of SOX9 and CD34 in alopecia areata.
    Bazid HAS; Marae AH; Farag B; Abdallah RA
    J Immunoassay Immunochem; 2024 Sep; 45(5):452-466. PubMed ID: 39041618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis.
    Strazzulla LC; Wang EHC; Avila L; Lo Sicco K; Brinster N; Christiano AM; Shapiro J
    J Am Acad Dermatol; 2018 Jan; 78(1):1-12. PubMed ID: 29241771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collapse of immune privilege in alopecia areata: coincidental or substantial?
    Gilhar A
    J Invest Dermatol; 2010 Nov; 130(11):2535-7. PubMed ID: 20944635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collapse and Restoration of Hair Follicle Immune Privilege Ex Vivo: A Model for Alopecia Areata.
    Fehrholz M; Bertolini M
    Methods Mol Biol; 2020; 2154():133-141. PubMed ID: 32314213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A "hair-raising" history of alopecia areata.
    Broadley D; McElwee KJ
    Exp Dermatol; 2020 Mar; 29(3):208-222. PubMed ID: 31960494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.